Patents by Inventor Gunter Pappert

Gunter Pappert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6635485
    Abstract: The invention concerns calibrators or calibration solutions which are based on a human serum matrix and which are used in a method for detecting cytokeratin, a process for producing them, a method for stabilizing cytokeratin and an immunological method for detecting cytokeratin in a sample.
    Type: Grant
    Filed: October 27, 2001
    Date of Patent: October 21, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Apostolos Kyriatsoulis, Gunter Pappert, Ellen Moessner, Norbert Franken, Michael Rottmann, Heinz Bodenmueller
  • Patent number: 6187270
    Abstract: The invention addresses a device for separating magnetic microparticles in a liquid with the aid of a magnetic field. During the separation procedure, the liquid containing the microparticles is located in the tip of the pipette. Moreover, the invention also addresses a method for separating microparticles, and a method for washing microparticles.
    Type: Grant
    Filed: July 6, 1995
    Date of Patent: February 13, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Urban Schmitt, Eberhard Maurer, Gunter Pappert
  • Patent number: 5981286
    Abstract: The present invention concerns new hydrophilic metal complexes and their use as luminescent marker groups in immunoassays.
    Type: Grant
    Filed: January 16, 1997
    Date of Patent: November 9, 1999
    Assignee: Roche Diagnostics, GmbH
    Inventors: Rupert Herrmann, Hans-Peter Josel, Gunter Pappert, Fritz Vogtle, Bruno Frommberger, Jorg Issberner
  • Patent number: 5614394
    Abstract: A method for making an monoclonal antibody specific for vitamin B12 by immunizing mice with vitamin B12-b-acid and isolating hybridomas that produce monoclonal antibodies which have an affinity constant for B12 greater than 5.times.10.sup.9 l/mol is disclosed.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: March 25, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Nicholas R. Hoyle, Gunter Pappert, Michael Grol, Christa Hubner-Parajsz
  • Patent number: 5460944
    Abstract: The present invention provides a storable POD conjugate solution, characterised by a pH value of 5.0 to 6.5, adjusted by means of an organic buffer substance with a concentration of 40 to 100 mmol/l, and 0.05 to 1.0 mol/l magnesium aspartate.
    Type: Grant
    Filed: April 21, 1993
    Date of Patent: October 24, 1995
    Assignee: Boehringer Mannheim GmbH
    Inventors: Norbert Franken, Nicholas Hoyle, Gunter Pappert
  • Patent number: 5451508
    Abstract: For the determination of vitamin B12 a sample solution is incubated with at least two receptors R.sub.1 and R.sub.2 of which R.sub.1 mediates the binding to the solid phase and R.sub.2 is labelled, whereby a receptor is used as one of the receptors R.sub.1 or R.sub.2 which contains a monoclonal antibody capable of specific binding to B12 that has an affinity constant of at least 5.times.10.sup.9 l/mol and a receptor is used as the other receptor R.sub.1 or R.sub.2 which contains B12 or an analogue thereof, the two phases are separated and the label is measured in one of the two phases.
    Type: Grant
    Filed: October 15, 1993
    Date of Patent: September 19, 1995
    Assignee: Boehringer Mannheim GmbH
    Inventors: Nicholas R. Hoyle, Gunter Pappert, Michael Grol, Christa Hubner-Parajsz
  • Patent number: 5300424
    Abstract: The present invention is concerned with a combination for the preservation of diagnostic tests, characterized by a content of at least two components selected from the group comprising 2-methyl-4-isothiazolin-3-one hydrochloride, 2-hydroxypyridine-N-oxide, chloroacetamide, (N,N-methylene-bis-(N-(1-hydroxymethyl-2,5-dioxo-4-imidazolidinyl))-urea and 5-bromo-5-nitro-1,3-dioxan.The present invention is also concerned with a preserved diagnostic test kit, comprising test reagents and at least two preservation agents selected from the group comprising 2-methyl-4-isothiazolin-3-one hydrochloride, 2-hydroxypyridine-N-oxide, chloroacetamide, (N,N-methylene-bis-(N-(1-hydroxymethyl)-2,5-dioxo-4-imidazolidinyl))-urea and 5-bromo-5-nitro-1,3-dioxan.
    Type: Grant
    Filed: July 12, 1991
    Date of Patent: April 5, 1994
    Assignee: Boehringer Mannheim GmbH
    Inventors: Gerhard Hoss, Gunter Pappert, Axel Schmidt
  • Patent number: 5118609
    Abstract: A carrier fleece is prepared for use as reagent carrier from which reagents can be dissolved in as assay such as immunological analysis. The carrier fleece contains from 5 to 60% by weight of cellulose-containing fibers, from 40 to 95% by weight of polyester or polyamide polymer fibers or a combination thereof and from 5 to 30% by weight of the fibers of an organic binding agent which has a hydroxyl or an ester group or a combination thereof. In an immunological analysis, the carrier fleece is impregnated with an immunologically active agent such as a beta-galactosidase conjugate and then introduced into a solution of a sample containing an immunologically active substance to be analyzed. The immunologically active agent is eluted into the sample solution and the presence of the immunologically active substance in the sample is determined.
    Type: Grant
    Filed: January 31, 1991
    Date of Patent: June 2, 1992
    Assignee: Boehringer Mannheim GmbH
    Inventors: Manfred Baier, Helmut Jering, Rolf Lerch, Dieter Mangold, Ellen Mossner, Gunter Pappert, Siegfried Notzel
  • Patent number: 4990443
    Abstract: The present invention provides hapten derivatives of the general formula: ##STR1## wherein Hap is a residue formed from a hapten carrying a keto or aldehyde group by splitting off an oxo group and R.sup.1 and R.sup.2, which can be the same or different, are alkyl radicals containing up to 7 carbon atoms and one of the symbols R.sup.1 and R.sup.2 can also represent a hydrogen atom.The present invention also provides hapten-protein conjugates of the general formula: ##STR2## wherein Hap, R.sup.1 and R.sup.2 have the above-given meanings and E--NH is the residue of a protein bound via an .epsilon.-amino group of a lysine residue.
    Type: Grant
    Filed: January 24, 1989
    Date of Patent: February 5, 1991
    Assignee: Boehringer Mannheim GmbH
    Inventors: Erasmus Huber, Christian Klein, Gunter Pappert, Klaus Hallermayer